Gruninger Marc
SEC Form 4 insider trading activity
Gruninger Marc has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Oct 29, 2026.
On the most recent filing, Gruninger Marc is listed as Director at Veraxa Biotech AG - Post de-SPAC. Inside the rolling window, Gruninger Marc reported 2 open-market purchases totaling $10K in VRXA and no open-market sales. The largest disclosed transaction in the window is a purchase of 9,133 VRXA shares on Oct 28, 2026, worth $9K.
Companies traded
Other insiders at VRXA
Insider Buying
$10K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Gruninger Marc made?
Gruninger Marc has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Gruninger Marc trade?
Gruninger Marc has filed SEC Form 4 disclosures for 1 company, including VRXA.
When was Gruninger Marc's most recent SEC Form 4 filing?
Gruninger Marc's most recent SEC Form 4 filing on Tracefour is dated Oct 29, 2026.
What is Gruninger Marc's total buy and sell value in the current window?
Inside the rolling retention window, Gruninger Marc bought $10K and sold $0 based on SEC Form 4 filings.
What was Gruninger Marc's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 9,133 VRXA shares on 2026-10-28, worth $9K, per SEC Form 4 filings.